AMR Bio Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

AMR Bio General Information

Description

Developer of anti infective pharmaceutical candidates intended for infection prevention. The company uses a proprietary ultra rapid antibacterial mechanism and supports preventative and dermal formulations, enabling healthcare providers to reduce post surgical staphylococcal infections and address antimicrobial resistance.

Contact Information

Website
www.amr-bio.com
Formerly Known As
Moirai Acquisitions
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 25 Old Burlington Street
  • Level 2
  • London
  • England, United Kingdom
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Corporate Office
  • 25 Old Burlington Street
  • Level 2
  • London
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AMR Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private Completed Pre-Clinical Trials
1. Early Stage VC 29-Sep-2025 Completed Pre-Clinical Trials
To view AMR Bio’s complete valuation and funding history, request access »

AMR Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view AMR Bio’s complete cap table history, request access »

AMR Bio Patents

AMR Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9326511-B2 Methods of inhibiting microbial biofilms Active 24-Oct-2008
US-20110262511-A1 Novel uses Active 24-Oct-2008
US-20070167619-A1 Novel uses of porphyrin compounds Active 23-Jun-2004
US-7977474-B2 Uses of porphyrin compounds Active 23-Jun-2004
US-20070281915-A1 Porphyrin derivatives and their use in photodynamic therapy Active 23-Dec-2002 C07D487/22
To view AMR Bio’s complete patent history, request access »

AMR Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
EMV Capital Venture Capital Minority
To view AMR Bio’s complete investors history, request access »

AMR Bio FAQs

  • When was AMR Bio founded?

    AMR Bio was founded in 2025.

  • Where is AMR Bio headquartered?

    AMR Bio is headquartered in London, United Kingdom.

  • What industry is AMR Bio in?

    AMR Bio’s primary industry is Drug Delivery.

  • Is AMR Bio a private or public company?

    AMR Bio is a Private company.

  • What is AMR Bio’s current revenue?

    The current revenue for AMR Bio is .

  • How much funding has AMR Bio raised over time?

    AMR Bio has raised $979K.

  • Who are AMR Bio’s investors?

    EMV Capital has invested in AMR Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process